Xeolas Pharmaceuticals Designated Activity Company
Summary
Xeolas Pharmaceuticals Designated Activity Company was set up on Thursday the 10th of May 2007. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 32 other Irish companies between them; 10 of which are now closed. Xeolas Pharmaceuticals Designated Activity Company has 15 shareholders.

Credit Score
- Latest Credit Movement:
- Date of Last Movement:01/06/2024
- Latest Accounts Filed:27/05/2024
- Report Based On Accounts:30/06/2023
- Next Set of Accounts Due:31/03/2025
- Overdue:No
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Xeolas Pharmaceuticals Designated Activity Company
- Time in Business:17 Years
- Company Number:439548
- Company Size:Medium Company
- Current Status:NORMAL
- Principal Activity:[24.42] Manufacture of Pharmaceutical Preparations
- May Trade As:
- Largest Company Shareholder:
- Registered Address:Hamilton Building,
Dcu Campus,
Dublin 9, Dublin
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Documents
Document | Pages | Effective | Received | Buy |
---|---|---|---|---|
NEW! Form B7 - Notice of Consolidation, Division, Conversion | 2 | 20/12/2024 | 28/02/2025 | |
Form B7 - Notice of Consolidation, Division, Conversion | 2 | 25/06/2024 | 19/12/2024 | |
AMENDED CONSTITUTION | 31 | 25/06/2024 | 19/12/2024 | |
Form B5 - Return of Allotments | 3 | 29/11/2024 | 19/12/2024 | |
Form G2 B4 for Increase Authorised Share Capital & Ordinary Resolution | 3 | 25/06/2024 | 19/12/2024 | |
Form B1C - Annual Return General | 7 | 31/03/2024 | 27/05/2024 | |
Migrated Certificate | 1 | null | 11/04/2007 |